These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia. Smits EL; Lee C; Hardwick N; Brooks S; Van Tendeloo VF; Orchard K; Guinn BA Cancer Immunol Immunother; 2011 Jun; 60(6):757-69. PubMed ID: 21519825 [TBL] [Abstract][Full Text] [Related]
3. Opportunities for immunotherapy in childhood acute myeloid leukemia. Lamble AJ; Tasian SK Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):218-225. PubMed ID: 31808843 [TBL] [Abstract][Full Text] [Related]
4. Immune-based therapeutics for pediatric cancer. Capitini CM; Mackall CL; Wayne AS Expert Opin Biol Ther; 2010 Feb; 10(2):163-78. PubMed ID: 19947897 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era? Liu Y; Bewersdorf JP; Stahl M; Zeidan AM Blood Rev; 2019 Mar; 34():67-83. PubMed ID: 30553527 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in AML: a brief review on emerging strategies. Moeinafshar A; Hemmati S; Rezaei N Clin Transl Oncol; 2021 Dec; 23(12):2431-2447. PubMed ID: 34160771 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of AML. Alatrash G; Molldrem JJ Cancer Treat Res; 2010; 145():237-55. PubMed ID: 20306255 [TBL] [Abstract][Full Text] [Related]
8. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia. Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332 [TBL] [Abstract][Full Text] [Related]
9. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in acute myeloid leukemia. Arpinati M; Curti A Immunotherapy; 2014; 6(1):95-106. PubMed ID: 24341888 [TBL] [Abstract][Full Text] [Related]
11. Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia. Agrawal V; Gbolahan OB; Stahl M; Zeidan AM; Zaid MA; Farag SS; Konig H Curr Cancer Drug Targets; 2020; 20(7):473-489. PubMed ID: 32357813 [TBL] [Abstract][Full Text] [Related]